Articles From: Covenant Transportation Group Announces Fourth Quarter and Year End Financial and Operating Results to Covidien Launches Response Effort in Support of Areas Impacted by Typhoon in the Philippines


2014/1/27
CHATTANOOGA, Tenn., Jan.
Sign-up for Covenant Transportation Group Announces Fourth Quarter and Year End Financial and Operating Results investment picks
2013/7/24
CHATTANOOGA, Tenn., July 24, 2013 (GLOBE NEWSWIRE) -- Covenant Transportation Group, Inc. (Nasdaq:CVTI) announced today financial and operating results for the second quarter ended June 30, 2013.
Sign-up for Covenant Transportation Group Announces Second Quarter Financial and Operating Results investment picks
CHATTANOOGA, Tenn., Nov.
Sign-up for Covenant Transportation Group, Inc. Announces Participation in Stephens Fall Investment Conference investment picks
2013/7/19
CHATTANOOGA, Tenn., July 19, 2013 (GLOBE NEWSWIRE) -- Covenant Transportation Group, Inc. (Nasdaq:CVTI) announced it plans to release its second quarter earnings in the late afternoon on Wednesday, July 24.
Sign-up for Covenant Transportation Group, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call investment picks
2014/4/1
Coventry Health Care today announced a new solution that could significantly reduce health care premiums for Iowa and Nebraska businesses with employees in other states.
Sign-up for Coventry Gives Iowa and Nebraska Businesses Access to New National Network Product investment picks
Coventry Health Care today announced the expansion of its Medicare Advantage service area to 26 counties across Louisiana and West Virginia and in 48 additional counties in 16 other states for 2014.
Sign-up for Coventry Health Care Will Now Offer Medicare Beneficiaries More Choice in More Regions across the United States investment picks
Accenture (NYSE:ACN) has been selected by Coverys, one of the top providers of medical professional liability insurance in the country, to transform the insurer’s software platform and support the company’s plans for future growth.
Sign-up for Coverys Selects Accenture’s Property and Casualty Software Suite as New Core Insurance System investment picks
By Nathalie Tadena Covidien PLC's (COV) fiscal fourth-quarter earnings fell 19% as the company recorded an increase in expenses and a slight decline in medical-supplies sales, however core earnings improved.
Sign-up for Covidien 4th-Quarter Profit Down 19% as Expenses Rise, Core Profits Up investment picks
2014/3/3
Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced its Puritan Bennett™ 980 ventilator has received European Economic Area (EEA) CE Mark approval.
Sign-up for Covidien Announces CE Mark Approval for Puritan Bennett™ 980 Ventilator investment picks
Covidien plc (NYSE: COV) and Given Imaging Ltd.
Sign-up for Covidien Announces Definitive Agreement to Acquire Given Imaging investment picks
2013/9/12
Covidien (NYSE: COV) , a leading global provider of healthcare products, today outlined the key strategic initiatives, growth opportunities and innovations that are expected to drive the Company’s growth in 2014 and beyond at a meeting held here for the investment community.
Sign-up for Covidien Announces Highlights from Investor Meeting investment picks
Covidien (NYSE: COV) , a leading global provider of healthcare products, today announced the agenda for its investor meeting on Thursday, September 12, 2013.
Sign-up for Covidien Announces Investor Meeting Agenda investment picks
Covidien plc (NYSE:COV) today provided further details regarding its previously disclosed realignment of reportable segments and announced additional changes in its revenue reporting format.
Sign-up for Covidien Announces Reporting Changes and Revised Revenue Guidance investment picks
2014/3/19
Covidien plc (NYSE: COV) announced the results from today’s Annual General Meeting.
Sign-up for Covidien Announces Results from 2014 Annual General Meeting investment picks
2014/1/13
Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one in Brazil and the other in China – that will enable it to help better meet the specific needs of underserved ‘value segment’ markets.
Sign-up for Covidien Announces Transactions Aimed at Emerging Markets ‘Value Segment’ investment picks
2014/2/26
Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced its Puritan Bennett™ 980 ventilator has received U.S. Food and Drug Administration (FDA) 510(k) clearance.
Sign-up for Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for the Puritan Bennett™ 980 Ventilator investment picks
SAN FRANCISCO (MarketWatch) -- Medical device maker Covidien PLC (COV) will acquire Given Imaging Ltd.
Sign-up for Covidien buying Given Imaging for $860 million investment picks
2014/1/27
Covidien plc (NYSE: COV) today announced that Charles J.
Sign-up for Covidien Chief Financial Officer Charles Dockendorff to Retire at End of Year investment picks
2014/2/27
Covidien plc (NYSE: COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multibillion dollar global gastrointestinal (GI) market.
Sign-up for Covidien Completes Acquisition of Given Imaging investment picks
2014/1/15
Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for approximately $235 million in cash.
Sign-up for Covidien Completes Sale of Confluent Surgical to Integra LifeSciences investment picks
2014/1/16
Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share.
Sign-up for Covidien Declares Quarterly Cash Dividend investment picks
2014/3/19
Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share.
Sign-up for Covidien Declares Quarterly Cash Dividend investment picks
2014/1/27
Covidien PLC (COV) filed a Form 8K - Changes in Company Executive Management - with the U.S Securities and Exchange Commission on January 21, 2014.
Sign-up for Covidien Files 8K - Changes Executive Management investment picks
Covidien PLC (COV) filed a Form 8K - Regulation FD Disclosure - with the U.S Securities and Exchange Commission on December 08, 2013.
Sign-up for Covidien Files 8K - Regulation FD investment picks
Covidien PLC (COV) filed a Form 8K - Regulation FD Disclosure - with the U.S Securities and Exchange Commission on December 16, 2013.
Sign-up for Covidien Files 8K - Regulation FD investment picks
2013/8/13
Covidien (NYSE: COV) , a leading global provider of healthcare products, announced the expansion of its portfolio of radiofrequency ablation (RFA) catheters with the launch of the Barrx™ Channel RFA Endoscopic Catheter for treating Barrett’s esophagus and certain gastrointestinal bleeding disorders 1 .
Sign-up for Covidien Introduces New Barrx™ RF Ablation Catheter for Treating Barrett’s Esophagus investment picks
2014/1/23
Further developing its capabilities in a key emerging market, Covidien (NYSE:COV) has officially opened its first training and education center in India.
Sign-up for Covidien Launches Advanced Medical Training and Education Center in India investment picks
2013/10/11
Covidien , a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today launched the Capnostream ® 20p bedside monitor.
Sign-up for Covidien Launches New Capnography Monitoring Solution investment picks
Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced it would donate $50,000 in support of relief efforts in communities devastated by Typhoon Haiyan in the Philippines.
Sign-up for Covidien Launches Response Effort in Support of Areas Impacted by Typhoon in the Philippines investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Covenant Transportation Group Announces Fourth Quarter and Year End Financial and Operating Results to Covidien Launches Response Effort in Support of Areas Impacted by Typhoon in the Philippines
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity